APEC is a 21-member trade forum characterized by strong public-private partnerships. It represents 55% of the world's GDP and includes China, Russia, Indonesia, Mexico and the U.S., among others. The forum’s ongoing health initiatives include regulatory convergence, anti-counterfeiting, codes of business conduct, and action plans to address NCDs. APEC Heads of State recognize that healthy populations are crucial for sustainable economic development and innovative growth. This session will explain APEC’s health workstreams and how they will promote profitability for life science companies in this important region of the world. 

Learning Objectives:

  • Assess ongoing work in APEC and its impact on business
  • Review how life sciences companies can promote APEC and its life sciences agenda
  • Evaluate how public-private partnerships leverage the goals of APEC

Ability Level: All

Session ID: 1928

myBIO Chatter

Speakers (4)

contact_9969 Kate Clemans Senior Director Crowell & Moring LLP
contact_4090 W. Mark Crowell Executive Director, UVa Innovation Associate VP for Research, University of Virginia
contact_9970 Atul Keshap Senior Official for Asia Pacific Economic Cooperation Bureau of East Asian and Pacific Affairs
User Mike Ward Co-chair, APEC Regulatory Harmonization Steering Committee Health Canada

Moderators (1)

contact_9971 Craig Kramer Vice President, International Global Government Affairs Johnson & Johnson

Who's Attending (2)

See all